Welcome to our dedicated page for BRUNSWICK SEC filings (Ticker: BC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on BRUNSWICK's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into BRUNSWICK's regulatory disclosures and financial reporting.
A shareholder of company BC has filed a Form 144 indicating an intent to sell 38,266 shares of common stock through Morgan Stanley Smith Barney LLC on or about 02/05/2026 on the NYSE. The filing lists an aggregate market value for these shares of $3,312,370.01 and notes that there are 65,036,590 shares of the same class outstanding.
The shares to be sold were acquired as performance shares from the issuer on 02/16/2023, in a non-cash transaction described as “Not Applicable” for the nature of payment. The signer represents they are not aware of undisclosed material adverse information about the issuer’s current or prospective operations.
Brunswick Corporation director J. Steven Whisler reported receiving 961 shares of Brunswick common stock on January 30, 2026, at a price of $80.22 per share. These are deferred shares credited to his director deferred account and will be paid out in predetermined installments after he leaves the board.
Following this transaction, Whisler beneficially owns 96,948 common shares directly, which include 517 shares from dividend reinvestments in December 2025, and an additional 1,000 shares indirectly held by a family trust.
Brunswick Corporation director David V. Singer reported acquiring 981 shares of the company’s common stock on January 30, 2026 at $80.22 per share. Following this transaction, he directly holds 35,203 shares, including 412 deferred shares that will be paid out after he leaves the board and 150 shares received through dividend reinvestment in December 2025.
In addition to his direct holdings, 19,789 shares are held indirectly through the Barbara B Singer 2014 Irrevocable Trust, reflecting additional beneficial ownership reported in this filing.
Brunswick Corporation director Joseph W. McClanathan reported an acquisition of company stock. On 01/30/2026, he acquired 934 shares of Brunswick common stock at $80.22 per share. After this transaction, he beneficially owned 26,898 shares held directly.
Footnotes explain that 412 of these shares are deferred into a director deferred account, to be distributed in installments after he leaves the board. His beneficial holdings also include 122 shares received through dividend reinvestment in December 2025.
Brunswick Corporation director Lauren Patricia Flaherty reported acquiring 522 shares of Brunswick common stock on January 30, 2026 at $80.22 per share. These are deferred shares credited to the director’s deferred account and are scheduled to be paid out in predetermined installments after she leaves the board.
Following this transaction, Flaherty beneficially owns 16,959 Brunswick shares, held directly. This total includes 94 shares that were added through dividend reinvestments in December 2025.
Brunswick Corporation director Roger Wood reported an acquisition of company stock through a Form 4 filing. On January 30, 2026, he acquired 545 shares of Brunswick common stock at a price of $80.22 per share, recorded as an acquisition of non-derivative securities.
Following this transaction, Wood beneficially owned 66,698 shares of Brunswick common stock, held directly. The filing notes that his beneficial holdings include 380 shares that were added earlier through dividend reinvestment in December 2025, and that the new shares are deferred and will be distributed after he ceases serving as a director.
Brunswick Corporation director David C. Everitt reported an acquisition of 697 shares of Brunswick common stock on January 30, 2026, at $80.22 per share. The shares were credited as deferred stock into his director deferred account and will be paid out in set installments after he leaves the board.
Following this transaction, Everitt directly beneficially owned 38,020 Brunswick shares, which include 215 shares acquired through dividend reinvestments in December 2025.
Brunswick Corporation director MaryAnn Wright received 541 deferred common shares at $80.22 each on January 30, 2026, bringing her direct beneficial ownership to 10,511 shares. These deferred shares are held in a director deferred account and will be distributed in predetermined installments after she leaves the board.
The filing also notes that her beneficial holdings include 57 shares acquired through dividend reinvestment in December 2025, reflecting ongoing accumulation of Brunswick stock via the company’s dividend reinvestment mechanism.
Brunswick Corporation director Nancy E. Cooper reported acquiring 549 shares of common stock on January 30, 2026 at a price of $80.22 per share. Following this transaction, she beneficially owned 27,632 shares held directly. This was reported as a routine insider Form 4 filing under SEC rules.
Brunswick Corporation director Reginald Fils-Aime reported acquiring additional common stock. On 01/30/2026, he acquired 561 shares of Brunswick common stock at a price of $80.22 per share. Following this transaction, he directly beneficially owned 10,885 shares of Brunswick common stock.